Showing results (1-10 of 67) with videos related to
Sort By:
Pageof 7
Cancer Cell & Microenvironment|May 26, 2015
Distinct phases of human prostate cancer initiation and progression can be driven by different cell-typesTanya Stoyanova, Andrew S GoldsteinAmerican Journal of Clinical and Experimental Urology|April 5, 2021
The role of Trop2 in prostate cancer: an oncogene, biomarker, and therapeutic targetMichelle Shen, Shiqin Liu, Tanya StoyanovaPharmacology & Therapeutics|July 29, 2022
Current and emerging therapies for neuroendocrine prostate cancerBusola Ruth Alabi, Shiqin Liu, Tanya StoyanovaMolecular Oncology|August 7, 2010
Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cellsAndrew S Goldstein, Tanya Stoyanova, Owen N WitteFrontiers in Oncology|September 27, 2019
Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate CancerMeghan A Rice, Sanjay V Malhotra, Tanya StoyanovaSeminars in Cancer Biology|May 21, 2022
Molecular mechanisms underlying the development of neuroendocrine prostate cancerShiqin Liu, Busola Ruth Alabi, Qingqing Yin, et al.Biology Methods & Protocols|August 11, 2021
Quantifying the invasion and migration ability of cancer cells with a 3D Matrigel drop invasion assayMerve Aslan, En-Chi Hsu, Shiqin Liu, et al.Proceedings of the National Academy of Sciences of the United States of America|June 23, 2009
DDB2 decides cell fate following DNA damageTanya Stoyanova, Nilotpal Roy, Dragana Kopanja, et al.Cell Cycle (Georgetown, Tex.)|November 20, 2009
DDB2 (damaged-DNA binding protein 2) in nucleotide excision repair and DNA damage responseTanya Stoyanova, Nilotpal Roy, Dragana Kopanja, et al.STAR Protocols|August 3, 2024
Protocol for establishing spontaneous metastasis in mice using a subcutaneous tumor modelShiqin Liu, Michelle Shen, Kewei Le, et al.Pageof 7